Literature DB >> 8163321

Indices of training stress during competitive running and swimming seasons.

M G Flynn1, F X Pizza, J B Boone, F F Andres, T A Michaud, J R Rodriguez-Zayas.   

Abstract

Eight male cross-country runners and five male swimmers were tested four times during their collegiate seasons. Each trial corresponded to a different training load. The runners' trials were conducted before the start of organized practice (RT1), after 3 wk of increased training (RT2), 3 wk prior to the conference championship (pre-taper, RT3), and 4 d after the conference championship (post-taper, RT4). The swimmers' trials were conducted after the first 9 wk of training (ST1), after completing 2 wk of hard training (ST2), after an additional 6 wk of training (pre-taper, ST3) and during a week following the conference championship (post-taper, ST4). Venous blood samples, heart rate (HR) and blood pressure (BP) were obtained after 15 min supine rest (0700 h). Serum was analyzed for cortisol (C), total testosterone (TT), free testosterone (FT), and creatine kinase (CK). Blood samples (lactate), HR and RPE were obtained during a fixed velocity run (75% preseason VO2max) and blood samples and RPE following a 365.8 m swim (90% preseason VO2max). The runners then completed a "performance run" to exhaustion (110% preseason VO2max) and the swimmers completed maximal 22.9 and 365.8 m swims. Serum CK, C, TT, FT, and the TT:C and FT:C ratios were not significantly different among trials for the runners. Serum TT and FT were significantly (P < 0.05) lower for the swimmers at ST2 (TT 16.7 +/- 2.5; FT 85.3 +/- 8.5) compared to ST1 (TT 30.3 +/- 2.8; FT 130.2 +/- 20.9) whereas, C, TT:C or FT:C were not significantly altered.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163321     DOI: 10.1055/s-2007-1021014

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  35 in total

Review 1.  The unknown mechanism of the overtraining syndrome: clues from depression and psychoneuroimmunology.

Authors:  Lawrence E Armstrong; Jaci L VanHeest
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 2.  Biochemical aspects of overtraining in endurance sports: a review.

Authors:  Cyril Petibois; Georges Cazorla; Jacques-Rémi Poortmans; Gérard Déléris
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

3.  Physically active men show better semen parameters and hormone values than sedentary men.

Authors:  Diana Vaamonde; Marzo Edir Da Silva-Grigoletto; Juan Manuel García-Manso; Natalibeth Barrera; Ricardo Vaamonde-Lemos
Journal:  Eur J Appl Physiol       Date:  2012-01-11       Impact factor: 3.078

Review 4.  Does overtraining exist? An analysis of overreaching and overtraining research.

Authors:  Shona L Halson; Asker E Jeukendrup
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

5.  Role of psychological stress in cortisol recovery from exhaustive exercise among elite athletes.

Authors:  F M Perna; S L McDowell
Journal:  Int J Behav Med       Date:  1995

Review 6.  Monitoring of performance and training in rowing.

Authors:  Jarek Mäestu; Jaak Jürimäe; Toivo Jürimäe
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

7.  Lifestyle, stress and cortisol response: Review II : Lifestyle.

Authors:  S Fukuda; K Morimoto
Journal:  Environ Health Prev Med       Date:  2001-04       Impact factor: 3.674

8.  Saliva cortisol, physical exercise and training: influences of swimming and handball on cortisol concentrations in women.

Authors:  E Filaire; P Duché; G Lac; A Robert
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 9.  Resistance exercise overtraining and overreaching. Neuroendocrine responses.

Authors:  A C Fry; W J Kraemer
Journal:  Sports Med       Date:  1997-02       Impact factor: 11.136

Review 10.  Physiological changes associated with the pre-event taper in athletes.

Authors:  Iñigo Mujika; Sabino Padilla; David Pyne; Thierry Busso
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.